IOVA - Iovance rallies nearly 40% on FDA approval stock offering
2024-02-20 11:11:17 ET
More on Iovance Biotherapeutics
- Iovance Biotherapeutics: Amtagvi's Pioneering Approval Sets New Standards In Melanoma
- Iovance: Approval For Historic Solid Tumor Targeting TIL Therapy Likely, Outlook Promising
- Iovance Biotherapeutics: Preparing For Volatility Around Lifileucel's Upcoming PDUFA Date
- Biggest stock movers today: Walmart, Discover Financial Services, Barclays, and more
- Iovance gets FDA accelerated approval for advanced melanoma therapy (update)